BBOT
#2703
BridgeBio Oncology Therapeutics, Inc. - Common Stock
8.7 4 USD
-0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.79%
Changement Mensuel
+2.82%
Evolution sur 6 mois
-12.25%
Changement Annuel
-3.10%
Clôture Précédente
9.1 8
Open
8.7 4
Low
8.7 4
High
8.7 4
Volume
31
Financials
- Market Capitalization 700.72 M
- Employee 88
- Founded 2016
- CEO N/A
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG01L3GYF02
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.01
ratio cours/chiffre d'affaires
0.15
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2677 |  NGNE Neurogene Inc. - Common Stock | 36.58 USD | -3.38% | -5.33% | +9.19% | +24.34% | 732.02 M USD | ||
| 2697 |  STTK Shattuck Labs, Inc. - Common Stock | 7.04 USD | -7.97% | -8.09% | -3.30% | +611.11% | 706.56 M USD | ||
| 2705 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.21 USD | -6.14% | -2.73% | -1.53% | +58.91% | 699.46 M USD | ||
| 2706 |  ALLO Allogene Therapeutics, Inc. - Common Stock | 2.02 USD | -3.35% | -4.27% | +2.54% | +80.36% | 697.89 M USD |